Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;170(8):1449-58.
doi: 10.1111/bph.12444.

The Concise Guide to PHARMACOLOGY 2013/14: overview

Stephen P H Alexander  1 , Helen E Benson, Elena Faccenda, Adam J Pawson, Joanna L Sharman, John C McGrath, William A Catterall, Michael Spedding, John A Peters, Anthony J Harmar; CGTP Collaborators; N Abul-Hasn, C M Anderson, C M H Anderson, M S Araiksinen, M Arita, E Arthofer, E L Barker, C Barratt, N M Barnes, R Bathgate, P M Beart, D Belelli, A J Bennett, N J M Birdsall, D Boison, T I Bonner, L Brailsford, S Bröer, P Brown, G Calo, W G Carter, W A Catterall, S L F Chan, M V Chao, N Chiang, A Christopoulos, J J Chun, J Cidlowski, D E Clapham, S Cockcroft, M A Connor, H M Cox, A Cuthbert, F M Dautzenberg, A P Davenport, P A Dawson, G Dent, J P Dijksterhuis, C T Dollery, A C Dolphin, M Donowitz, M L Dubocovich, L Eiden, K Eidne, B A Evans, D Fabbro, C Fahlke, R Farndale, G A Fitzgerald, T M Fong, C J Fowler, J R Fry, C D Funk, A H Futerman, V Ganapathy, B Gaisnier, M A Gershengorn, A Goldin, I D Goldman, A L Gundlach, B Hagenbuch, T G Hales, J R Hammond, M Hamon, J C Hancox, R L Hauger, D L Hay, A J Hobbs, M D Hollenberg, N D Holliday, D Hoyer, N A Hynes, K-I Inui, S Ishii, K A Jacobson, G E Jarvis, M F Jarvis, R Jensen, C E Jones, R L Jones, K Kaibuchi, Y Kanai, C Kennedy, I D Kerr, A A Khan, M J Klienz, J P Kukkonen, J Y Lapoint, R Leurs, E Lingueglia, J Lippiat, S J Lolait, S C R Lummis, J W Lynch, D MacEwan, J J Maguire, I L Marshall, J M May, C A McArdle, J C McGrath, M C Michel, N S Millar, L J Miller, V Mitolo, P N Monk, P K Moore, A J Moorhouse, B Mouillac, P M Murphy, R R Neubig, J Neumaier, B Niesler, A Obaidat, S Offermanns, E Ohlstein, M A Panaro, S Parsons, R G Pwrtwee, J Petersen, J-P Pin, D R Poyner, S Prigent, E R Prossnitz, N J Pyne, S Pyne, J G Quigley, R Ramachandran, E L Richelson, R E Roberts, R Roskoski, R A Ross, M Roth, G Rudnick, R M Ryan, S I Said, L Schild, G J Sanger, K Scholich, A Schousboe, G Schulte, S Schulz, C N Serhan, P M Sexton, D R Sibley, J M Siegel, G Singh, R Sitsapesan, T G Smart, D M Smith, T Soga, A Stahl, G Stewart, L A Stoddart, R J Summers, B Thorens, D T Thwaites, L Toll, J R Traynor, T B Usdin, R J Vandenberg, C Villalon, M Vore, S A Waldman, D T Ward, G B Willars, S J Wonnacott, E Wright, R D Ye, A Yonezawa, M Zimmermann
Affiliations

The Concise Guide to PHARMACOLOGY 2013/14: overview

Stephen P H Alexander et al. Br J Pharmacol. 2013 Dec.

Abstract

The Concise Guide to PHARMACOLOGY 2013/14 provides concise overviews of the key properties of over 2000 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties from the IUPHAR database. The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.12444/full. This compilation of the major pharmacological targets is divided into seven areas of focus: G protein-coupled receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear hormone receptors, transporters and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. A new landscape format has easy to use tables comparing related targets. It is a condensed version of material contemporary to late 2013, which is presented in greater detail and constantly updated on the website www.guidetopharmacology.org, superseding data presented in previous Guides to Receptors & Channels. It is produced in conjunction with NC-IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate. It consolidates information previously curated and displayed separately in IUPHAR-DB and GRAC and provides a permanent, citable, point-in-time record that will survive database updates.

PubMed Disclaimer

Similar articles

  • The Concise Guide to PHARMACOLOGY 2013/14: ion channels.
    Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators. Alexander SP, et al. Br J Pharmacol. 2013 Dec;170(8):1607-51. doi: 10.1111/bph.12447. Br J Pharmacol. 2013. PMID: 24528239 Free PMC article.
  • The Concise Guide to PHARMACOLOGY 2013/14: enzymes.
    Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators. Alexander SP, et al. Br J Pharmacol. 2013 Dec;170(8):1797-867. doi: 10.1111/bph.12451. Br J Pharmacol. 2013. PMID: 24528243 Free PMC article.
  • The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.
    Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators. Alexander SP, et al. Br J Pharmacol. 2013 Dec;170(8):1582-606. doi: 10.1111/bph.12446. Br J Pharmacol. 2013. PMID: 24528238 Free PMC article.
  • THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels.
    Alexander SPH, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators. Alexander SPH, et al. Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S142-S228. doi: 10.1111/bph.14749. Br J Pharmacol. 2019. PMID: 31710715 Free PMC article. Review.
  • THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets.
    Alexander SPH, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, Fabbro D, Spedding M, Striessnig J, Davies JA; CGTP Collaborators. Alexander SPH, et al. Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S1-S20. doi: 10.1111/bph.14747. Br J Pharmacol. 2019. PMID: 31710719 Free PMC article. Review.
See all similar articles

Cited by

See all "Cited by" articles

References

Further reading

    1. Buechler C. Wanninger J. Neumeier M. Adiponectin receptor binding proteins–recent advances in elucidating adiponectin signalling pathways. FEBS Lett. 2010;584:4280–4286. [PMID:20875820] - PubMed
    1. Dalamaga M. Diakopoulos KN. Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33:547–594. [PMID:22547160] - PMC - PubMed
    1. Goldstein BJ. Scalia RG. Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 2009;6:27–35. [PMID:19029992] - PMC - PubMed
    1. Juhl C. Beck-Sickinger AG. Molecular tools to characterize adiponectin activity. Vitam Horm. 2012;90:31–56. [PMID:23017711] - PubMed
    1. Shetty S. Kusminski CM. Scherer PE. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci. 2009;30:234–239. [PMID:19359049] - PubMed

References

    1. Alexander SPH, et al. Br J Pharmacol. 2011;164:S1–S324. PM: 22040146. - PMC - PubMed
    1. Vanhoutte PM, et al. Pharmacol Rev. 1996;48:1–2. PM: 8685244. - PubMed
    1. Hug C, et al. Proc Natl Acad Sci U S A. 2004;101:10308–10313. [PMID: 15210937 ] - PMC - PubMed
    1. Maeda K, et al. Biochem Biophys Res Commun. 1996;221:286–289. [PMID: 8619847 ] - PubMed
    1. Mao X, et al. Nat Cell Biol. 2006;8:516–523. [PMID: 16622416 ] - PubMed

Publication types